The levels of both Az1 and AZIN have been evaluated in several cancers and corresponding normal tissues, which indicate that Az1 levels are indeed reduced with a concomitant increase in AZIN levels in cancers (Olsen and Zetter, 2011), supporting a model in which a decrease in Az1 levels and/or activity promotes cancer development. This evidence concerns the gene OAZ1 and cancer.